MedTrace Logo

Role of Metabolomics in the Diagnosis of Endometriosis

NCT02337816 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2018-11-06

No results posted yet for this study

Summary

Endometriosis is one of the most common benign gynecological, affecting about 10% of premenopausal women. The pathophysiology of this disease is still not completely clear. Despite its prevalence, there is no blood test available for the diagnosis of endometriosis and the average delay time to diagnosis is 9.4 years.

Metabolomics is a scientific discipline that studies changes in metabolites related to the pathophysiology of the disease.

Aim of the study is to identify an alteration in the expression of the metabolites in women with endometriosis

Conditions

  • Endometriosis

Interventions

PROCEDURE

laparoscopic surgery, obtainment of biological samples

Sponsors & Collaborators

  • University of Cagliari

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2016-06-30
Completion
2016-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02337816 on ClinicalTrials.gov